| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Drug Metabolism, Faculty of Pharmaceutical Sciences, Hokkaido University, N12 W6, Sapporo, Hokkaido 060, Japan [Y. Y., M. S., T. K.]; Department of Molecular Neurobiology, Tokyo Metropolitan Institute for Neurosciences, 2-6 Musashidai, Fuchu, Tokyo 183, Japan [T. D.]; and Laboratory of Molecular Carcinogenesis, National Institutes of Health, Bethesda, Maryland 20892 [F. J. G.]
In order to investigate the metabolic activation pathway of food-derived heterocyclic amines, 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), cultured cell lines which stably expressed human cytochrome P4501A2 (CYP1A2) and N-acetyltransferases (NATs) were developed by the method of complementary DNA (cDNA) transfection. First, a cell line expressing CYP1A2, designated A2R-5, was established from the cell line CR-68, which was previously established by introducing NADPH-cytochrome P-450 reductase cDNA into Chinese hamster CHL cells. The expression of CYP1A2 in the transfected cells was confirmed by determining sensitivity to aflatoxin B1. As the next step, the A2R-5 as well as CR-68 cells were further transfected with human monomorphic NAT (NAT1) or polymorphic NAT (NAT2) cDNAs. The expression of NAT in the transfected cells was confirmed using p-aminobenzoic acid and sulfamethazine as substrates, while no activity was seen in parental CR-68 and A2R-5 cells. The cell line, ANP-25, which expressed both CYP1A2 and NAT2, was approximately 370- and 100-fold more sensitive to IQ and MeIQx, respectively, than parental CR-68 cells in cytotoxicity assays. There were no clear differences in sensitivity to both compounds among CR-68, A2R-5, and the cell lines which expressed NAT1 alone, NAT2 alone, and CYP1A2 plus NAT1. Mutagenicity of IQ and MeIQx at the hypoxanthine-guanine phosphoribosyltransferase locus was also detectable only in ANP-25 cells but not in A2R-5 or the cell line expressing CYP1A2 plus NAT1. From these results, it is proposed that both CYP1A2 and NAT2 (but not NAT1) are required for mutagenic activation of these compounds, implying that acetylator polymorphism may be an important risk factor in the carcinogenicity of these compounds.
1 This work was supported partly by a grant-in-aid for scientific research from the Ministry of Education, Science and Culture of Japan and by the Japan Health Sciences Foundation.
2 Present address: Division of Environmental Hygiene, Hokkaido Institute of Pharmaceutical Sciences, 7-1 Katsuraoka-cho, Otaru, Hokkaido 047-02, Japan.
3 Present address: Research and Development Division, BML, Inc., 1361-1 Matoba, Kawagoe, Saitama 350, Japan.
4 To whom requests for reprints should be addressed.
Received 12/ 6/93. Accepted 5/ 3/94.
This article has been cited by other articles:
![]() |
J. Bendaly, S. Zhao, J. R. Neale, K. J. Metry, M. A. Doll, J. C. States, W. M. Pierce Jr., and D. W. Hein 2-Amino-3,8-Dimethylimidazo-[4,5-f]Quinoxaline-Induced DNA Adduct Formation and Mutagenesis in DNA Repair-Deficient Chinese Hamster Ovary Cells Expressing Human Cytochrome P4501A1 and Rapid or Slow Acetylator N-Acetyltransferase 2 Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1503 - 1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Goldman and P. G. Shields Food Mutagens J. Nutr., March 1, 2003; 133(3): 965S - 973. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Miranda, Y.-H. Yang, M. C. Henderson, J. F. Stevens, G. Santana-Rios, M. L. Deinzer, and D. R. Buhler Prenylflavonoids from Hops Inhibit the Metabolic Activation of the Carcinogenic Heterocyclic Amine 2-Amino-3-methylimidazo[4,5-f]quinoline, Mediated by cDNA-Expressed Human CYP1A2 Drug Metab. Dispos., November 1, 2000; 28(11): 1297 - 1302. [Abstract] [Full Text] |
||||
![]() |
G. Paladino, B. Weibel, and C. Sengstag Heterocyclic aromatic amines efficiently induce mitotic recombination in metabolically competent Saccharomyces cerevisiae strains Carcinogenesis, November 1, 1999; 20(11): 2143 - 2152. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A.J. Schut and E. G. Snyderwine DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis Carcinogenesis, March 1, 1999; 20(3): 353 - 368. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |